News from oramed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 17, 2013, 08:10 ET

Oramed's Platform Technology in Oral Delivery of Proteins Receives Patent in Russia

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been...

Sep 10, 2013, 08:10 ET

Oramed Granted Patent in China for its Platform Technology in Oral Delivery of Proteins

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...

Sep 03, 2013, 08:10 ET

Oramed Submits Pre-IND Package to FDA for ORMD-0901 (oral exenatide), an Oral GLP-1 Analog for the Treatment of Type 2 Diabetes

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...

Aug 21, 2013, 08:10 ET

Oramed Initiates Patient Recruitment for a New Clinical Trial in Israel of its Oral Insulin Drug ORMD-0801 in the Treatment of Type 1 Diabetes

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...

Jul 30, 2013, 08:10 ET

Oramed Submits Pre-IND Meeting Request to FDA for its Oral Exenatide Capsule ORMD-0901

 Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today that it submitted a...

Jul 10, 2013, 17:58 ET

Oramed to Raise $4,600,000 in Registered Direct Offering

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, today announced it has entered into definitive agreements...

Jul 08, 2013, 08:15 ET

Oramed Enrolls First Patient in its Phase 2a U.S. Oral Insulin Clinical Trial

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the first...

Jul 02, 2013, 12:38 ET

Oramed to Present at the 8th Annual JMP Securities Healthcare Conference in New York City

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the...

Jun 21, 2013, 10:30 ET

Oramed Pharmaceuticals to Present Findings on Oral Insulin to the American Diabetes Association

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it will be...

Jun 21, 2013, 08:05 ET

Oramed Pharmaceuticals Announces Withdrawal of Proposed Underwritten Public Offering

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...

Jun 10, 2013, 07:45 ET

Oramed Pharmaceuticals to Present at IATI-BioMed Conference in Israel

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a clinical-stage developer of oral delivery systems, announced today that it has been invited to...

Jun 03, 2013, 04:12 ET

Oramed Selected to Present at the 81st European Atherosclerosis Society Congress in Lyon, France, June 2-5, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its...

May 30, 2013, 07:40 ET

Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its wholly...

May 28, 2013, 09:40 ET

Oramed CEO to Present at New York Biotechnology Association and The Israel Conference's Fast & Cool™ Session

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the...

May 17, 2013, 07:50 ET

Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the United...

May 01, 2013, 07:15 ET

Clinical Results for Oramed's Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems of drugs currently administered by...

Apr 29, 2013, 07:40 ET

Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems of drugs currently administered by...

Apr 22, 2013, 09:15 ET

Oramed CEO to be Panelist at BIO International Convention Breakout Session on Israel Becoming Biotech Leader

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that the Company's CEO...

Apr 18, 2013, 03:21 ET

Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that its abstract,...

Apr 16, 2013, 09:15 ET

Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced a key addition to...